Buchumschlag

Case series of patients with laboratory-confirmed Marburg virus disease in 2023 in Equatorial Guinea

Marburg virus disease (MVD) is a severe viral infection caused by the Marburg marburgvirus species. In February 2023, Equatorial Guinea declared its first outbreak. This case series describes the natural history of MVD in 5 patients with laboratory-confirmed disease.Patients with confirmed MVD who w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ondo Ndoho, Florentino Abaga (VerfasserIn) , Fontana, Luca (VerfasserIn) , Avomo, Candido Ondo Ondo (VerfasserIn) , Mikue, Ladislao Ekiri Ngomo (VerfasserIn) , Eyemam, Domitila Ñadang Fuga (VerfasserIn) , Nguere, Micaela Ayang (VerfasserIn) , Mometolo, Ilda Elobe (VerfasserIn) , Nzang, Rosalia Nazang Bibang (VerfasserIn) , Maye, Damaso Mitogo Nguema (VerfasserIn) , Hernandez Suarez, Yosbanis (VerfasserIn) , Esono, Salvador Eduardo (VerfasserIn) , Miko Ayang, José Antonio (VerfasserIn) , Giuliani, Ruggero (VerfasserIn) , Jacquerioz, Frédérique (VerfasserIn) , Lang, Hans-Jörg (VerfasserIn) , Kojan, Richard (VerfasserIn) , Chaillon, Antoine (VerfasserIn) , Ngai, Stephanie (VerfasserIn) , de Waroux, Olivier le Polain (VerfasserIn) , Silenzi, Anna (VerfasserIn) , Di Marco, Michele (VerfasserIn) , Legand, Anaïs (VerfasserIn) , Formenty, Pierre (VerfasserIn) , Negron, Maria E (VerfasserIn) , Klena, John D (VerfasserIn) , Choi, Mary J (VerfasserIn) , Mayer, Oren (VerfasserIn) , Scholte, Florine E M (VerfasserIn) , Welch, Stephen R (VerfasserIn) , Gutierrez, Emily Zielinski (VerfasserIn) , Diaz, Janet (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 24 April 2025
In: Clinical infectious diseases
Year: 2025, Jahrgang: 81, Pages: 1-9
ISSN:1537-6591
DOI:10.1093/cid/ciaf208
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1093/cid/ciaf208
Verlag, kostenfrei, Volltext: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf208/8119364?login=true
Volltext
Verfasserangaben:Florentino Abaga Ondo Ndoho, Luca Fontana, Candido Ondo Ondo Avomo, Ladislao Ekiri Ngomo Mikue, Domitila Ñadang Fuga Eyemam, Micaela Ayang Nguere, Ilda Elobe Mometolo, Rosalia Nazang Bibang Nzang, Damaso Mitogo Nguema Maye, Yosbanis Hernandez Suarez, Salvador Eduardo Esono, José Antonio Miko Ayang, Ruggero Giuliani, Frédérique Jacquerioz, Hans-Joerg Lang, Richard Kojan, Antoine Chaillon, Stephanie Ngai, Olivier le Polain de Waroux, Anna Silenzi, Michele Di Marco, Anaïs Legand, Pierre Formenty, Maria E. Negron, John D. Klena, Mary J. Choi, Oren Mayer, Florine E.M. Scholte, Stephen R. Welch, Emily Zielinski Gutierrez, and Janet Diaz
Beschreibung
Zusammenfassung:Marburg virus disease (MVD) is a severe viral infection caused by the Marburg marburgvirus species. In February 2023, Equatorial Guinea declared its first outbreak. This case series describes the natural history of MVD in 5 patients with laboratory-confirmed disease.Patients with confirmed MVD who were admitted to the national treatment center in Bata, Equatorial Guinea were monitored for vital signs and symptoms. Comprehensive clinical data were collected to understand the progression and outcome of the disease.Five patients were confirmed to have MVD. Three male healthcare workers received a diagnosis diagnosed early in their disease and subsequently survived. The other 2 patients, both female, were admitted later in their disease progression and died within 24 hours of admission. Four patients received remdesivir under a protocol for the monitored emergency use of unregistered and experimental interventions. The early symptoms were nonspecific, with rapid progression to more severe conditions in the later stages of the disease. Early treatment with remdesivir showed the drug to be well tolerated.Contrary to some reports and the recommended case definition for MVD, our patients presented with a rash but did not exhibit vomiting or diarrhea. Hemorrhagic signs were solely observed in the terminal stage, preceding demise. Despite the limited sample size, these findings emphasize the importance of tailoring the case definition to the specific outbreak. Further evidence on the efficacy and safety of therapeutics for MVD, including remdesivir, should be gathered through well-designed trials during future epidemic responses.
Beschreibung:Gesehen am 03.11.2025. Online ahead of print
Beschreibung:Online Resource
ISSN:1537-6591
DOI:10.1093/cid/ciaf208

Ähnliche Einträge